Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says
7 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression trial, CEO says" is generating significant coverage in the Business category, with 7 articles from 7 distinct sources tracked by PULSE so far.
Outlets currently covering the story include BioSpace, Yahoo Finance, Psychedelic Alpha and WSJ. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 49d ago.
Quick answers
Why is "Definium’s LSD formula produces ‘best data ever seen’ in a pivotal depression tr" trending?
Because 7 independent news sources published 7 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Definium’s LSD-based therapy elicits ‘profound’ efficacy in Phase 3 depression trial BioSpace · 51d ago
- Definium Therapeutics (DFTX) Hits New High on Impressive Drug Candidate Trial Yahoo Finance · 51d ago
- Breaking: Definium Lands Positive Phase 3, LSD Candidate Shows Strong Antidepressant Effect Psychedelic Alpha · 51d ago
- 🔎 Under the Radar: Definium Shares Propelled by Strong Psychedelic Results WSJ · 51d ago
- Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder Business Wire · 51d ago
- Definium's LSD-based drug scores win in key major depressive disorder study FirstWord Pharma · 51d ago
- Definium LSD therapy helped patients with major depression in late-stage trial statnews.com · 51d ago
Topics
Related trends
Biotech Scores Again With LSD In Anxiety; Stock Rises
3 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Definium hits another phase 3 homerun with psychedelic ‘sea change’ for anxiety
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Home Depot CEO taking temporary medical leave, two top execs to run the retailer
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Norway wealth fund CEO says fund's entire value could be lost if market collapses
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Dodge's CEO Says The Best Is Yet To Come: 'We're Going To Go Faster'
4 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.
Xbox CEO Reacts to Live Demo of The Elder Scrolls 6: 'The Scale and Grandeur Are Incredible'
2 news sources are covering this Technology story right now — PULSE is tracking how fast it spreads.